Bioceramics Market Report 2025

This report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.

The bioceramics market size has grown strongly in recent years. It will grow from $4.14 billion in 2024 to $4.43 billion in 2025 at a compound annual growth rate (CAGR) of 6.9%. The growth in the historic period can be attributed to increasing aging population, growing incidence of chronic diseases, demand for aesthetic dentistry, regulatory approvals and standards, increased focus on regenerative medicine.

The bioceramics market size is expected to see strong growth in the next few years. It will grow to $5.73 billion in 2029 at a compound annual growth rate (CAGR) of 6.6%. The growth in the forecast period can be attributed to rising demand for bioactive ceramics, expanding applications in neurology, growing awareness of dental health, international collaborations in medical research, focus on personalized medicine. Major trends in the forecast period include emergence of advanced 3d printing techniques, development of multifunctional bioceramic materials, utilization of nanotechnology in bioceramic design, introduction of antibacterial bioceramics, focus on bioresorbable bioceramics for temporary implants, advancements in bioceramic coatings for implants.

The increasing prevalence of orthopedic and dental disorders is projected to drive the growth of the bioceramics market in the future. Orthopedic and dental disorders are two distinct types of medical conditions, with orthopedic disorders primarily affecting the musculoskeletal system and dental disorders impacting oral health and the structures within the mouth. Bioceramics are extensively used in both orthopedics and dentistry due to their biocompatibility, durability, and ability to mimic the properties of natural bones and teeth. In orthopedics, they are commonly utilized for implantation, such as in hip and knee joint replacements. Similarly, in dentistry, bioceramics are widely applied in various dental restorations, including crowns, bridges, and dental implants. For instance, in July 2022, the UK Health Security, a public health government agency, reported a notable 10.2% increase in mandatory orthopedic procedure submissions, reaching 102,025 for the financial year 2022 to 2023. Additionally, in March 2023, the World Health Organization, a Switzerland-based government organization, estimated that oral diseases affect nearly 3.5 billion people globally in 2022. Furthermore, in February 2024, the British Dental Association, a UK-based health organization, reported that over 12 million adults in England have unmet dental needs. Thus, the growing prevalence of orthopedic and dental disorders is expected to boost the bioceramics market.

The increasing incidence of cardiovascular diseases is anticipated to fuel the growth of the bioceramics market in the coming years. Cardiovascular diseases (CVDs) encompass a range of disorders affecting the heart and blood vessels, including coronary heart disease, cerebrovascular disease, peripheral arterial disease, and aortic atherosclerosis. Bioceramics play a crucial role in the context of cardiovascular diseases by serving as implantable materials in medical devices such as artificial heart valves and stents, enhancing biocompatibility and durability in cardiac interventions. For example, in September 2024, a report from the British Heart Foundation (BHF), a UK-based charity that funds research and promotes awareness about heart and circulatory diseases, indicated that around 7.6 million individuals in the UK are affected by heart and circulatory diseases. By 2030, the number of individuals living with these diseases in the UK could increase by an additional 1 million, with a further rise of 2 million expected by 2040, on top of current figures. Therefore, the increasing incidence of cardiovascular diseases is propelling the growth of the bioceramics market.

Leading companies in the bioceramics market are introducing advanced materials such as LithaBone HA 480 to enhance bioceramic implants' performance and the quality of 3D-printed bone implants. LithaBone HA 480, a hydroxyapatite (HA) type, is designed for the production of patient-specific ceramic implants, offering improved wall thickness and enhanced geometric flexibility. The launch of this innovative material by Lithoz GmbH showcases the commitment to revolutionize bone implant manufacturing, making them more effective, affordable, and accessible for diverse medical applications such as bone grafts, dental implants, and orthopedic prostheses.

In July 2023, SHS Gesellschaft fur Beteiligungsmanagement mbH, a Germany-based independent private equity firm, successfully acquired a majority stake in CAM Bioceramics for an undisclosed sum. This strategic acquisition is geared toward fortifying and expanding SHS's presence in the realm of innovative calcium phosphate solutions within the medical industry. The move is anticipated to propel the company's growth and success in the burgeoning bioceramics market. CAM Bioceramics, headquartered in the Netherlands, specializes in the manufacturing of bioceramics for applications in the medical and healthcare sectors.

Major companies operating in the bioceramics market report are Stryker Corporation, Kyocera Corporation, The Royal DSM Company, Zimmer-Biomet Holdings Inc., Dentsply Sirona, NGK Spark Plug Co. Ltd., Straumann Group, Morgan Advanced Materials PLC, CoorsTek Medical, Carborundum Universal Ltd., Washington Mills Ceramics Corporation, Saint-Gobain Ceramics And Plastics Inc., H.C. Starck Ceramics GmbH, Nobel Biocare Holding AG, Ceram Tec, Nabertherm GmbH., Collagen Matrix Inc., DePuy Synthes Inc., CamBioceramics, Sagemax Bioceramics, Astro Met Inc., Bonesupport AB, Berkeley Advanced BioTypes Inc., Matexcel, Jyoti Ceramic Industries Pvt. Ltd., Doceram Medical Ceramics GmbH, Amedica Corporation, BIOMATCAN Ltd., CaP Biomaterials LLC, IJ Research Inc.

North America was the largest region in the bioceramics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the bioceramics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the bioceramics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The bioceramics market consists of sales of bio-conductive ceramics, piezoelectric ceramics, radiopaque ceramics and composite bioceramics. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

Bioceramics represent a category of biomaterials composed of ceramic compounds, specifically engineered for applications in medical and healthcare settings, including the repair or replacement of damaged bone tissue, joints, and other organs.

The primary types of bioceramics include bioinert, bioactive, and bioresorbable. Bioinert characterizes materials or substances with minimal reactivity, and examples encompass aluminum oxide, zirconia, calcium phosphate, and others. These bioinert bioceramics find applications in various medical fields such as orthopedics, dental implants, biomedical applications, and more.

The bioceramics market research report is one of a series of new reports that provides bioceramics market statistics, including bioceramics industry global market size, regional shares, competitors with a bioceramics market share, detailed bioceramics market segments, market trends and opportunities, and any further data you may need to thrive in the bioceramics industry. This bioceramics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.